Arctic Bioscience AS
ABS
Rank in Stocks
#29633
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Γrsta, Norway.
Share Price
$0.27120727
Last synced: 2026-11-09
Market Cap
$7.31M
Change (1 day)
7.36%
Change (1 year)
-28.95%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Arctic Bioscience AS (ABS)
Category
Healthcare
Operating Margin for Arctic Bioscience AS (ABS)
Operating Margin as of November 2026 TTM: -68.51%
According to Arctic Bioscience AS's latest financial reports, its current operating margin (TTM) is -68.51%. At the end of 2025 the company had an operating margin of -89.71%.
Operating Margin history for Arctic Bioscience AS from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -68.51% | -23.63% |
| 2025 | -89.71% | -18.37% |
| 2024 | -109.90% | -23.64% |
| 2023 | -143.93% | 31.92% |
| 2022 | -109.10% | -157.85% |
| 2021 | 188.60% | -278.35% |
| 2020 | -105.75% | 930.70% |
| 2019 | -10.26% | 121.60% |
| 2018 | -4.63% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.56% |
US
|
|
| -149.01% | -97.82% |
US
|
|
| 25.57% | -100.37% |
AU
|
|
| 31.23% | -100.46% |
BE
|
|
| 29.35% | -100.43% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Arctic Bioscience AS's operating margin
What is Arctic Bioscience AS's operating margin?
Arctic Bioscience AS's operating margin is -68.51%, as of Nov 2026.
What was Arctic Bioscience AS's operating margin in 2025?
In 2025, Arctic Bioscience AS's operating margin was -89.71%, compared with -109.90% in 2024.
How has Arctic Bioscience AS's operating margin changed since 2020?
From 2020 to 2025, Arctic Bioscience AS's operating margin was highest in 2021 (188.60%) and lowest in 2023 (-143.93%).
How does Arctic Bioscience AS's operating margin compare with similar companies?
Arctic Bioscience AS's operating margin (-68.51%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.